Form 483

Mylan Laboratories Limited Form 483, 2017-05-15

FDA issued a Form 483 to Mylan Laboratories Limited on 2017-05-15 with 18 public-safe observations.

483· Form 483 issuedHuman Drugs18 observations

Mylan Laboratories Limited · Hosur, India · Issued May 15, 2017

Overview

  • 18 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 May 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Michael A Charles

15 May 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Michael A Charles

15 May 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Michael A Charles

15 May 2017
21 CFR 211.192

Written record of investigation incomplete

Cited by Michael A Charles

15 May 2017
21 CFR 211.192

Written record of investigation incomplete

Cited by Michael A Charles

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations3x
21 CFR 211.192Cited across public-safe Form 483 observations3x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations3x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations3x
21 CFR 211.52Cited across public-safe Form 483 observations3x
21 CFR 211.67(a)Cited across public-safe Form 483 observations3x

Full 483 report

Get the verbatim text of all 18 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere